CAM2038

buprenorphine · Braeburn Pharmaceuticals

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CAM2038, covering 2019-08-01 to 2021-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain [Phase 3]